IL105607A - Polycyclic macrolides containing atomic tetra, their preparation and pharmaceutical preparations containing them - Google Patents

Polycyclic macrolides containing atomic tetra, their preparation and pharmaceutical preparations containing them

Info

Publication number
IL105607A
IL105607A IL105607A IL10560793A IL105607A IL 105607 A IL105607 A IL 105607A IL 105607 A IL105607 A IL 105607A IL 10560793 A IL10560793 A IL 10560793A IL 105607 A IL105607 A IL 105607A
Authority
IL
Israel
Prior art keywords
hydroxy
compound
group
formula
formulae
Prior art date
Application number
IL105607A
Other languages
English (en)
Hebrew (he)
Other versions
IL105607A0 (en
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929209815A external-priority patent/GB9209815D0/en
Priority claimed from GB939304927A external-priority patent/GB9304927D0/en
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of IL105607A0 publication Critical patent/IL105607A0/xx
Publication of IL105607A publication Critical patent/IL105607A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/18—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Saccharide Compounds (AREA)
IL105607A 1992-05-07 1993-05-05 Polycyclic macrolides containing atomic tetra, their preparation and pharmaceutical preparations containing them IL105607A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929209815A GB9209815D0 (en) 1992-05-07 1992-05-07 Organic compounds,processes for their production and their use
GB939304927A GB9304927D0 (en) 1993-03-10 1993-03-10 Organic compounds

Publications (2)

Publication Number Publication Date
IL105607A0 IL105607A0 (en) 1993-09-22
IL105607A true IL105607A (en) 1998-01-04

Family

ID=26300836

Family Applications (1)

Application Number Title Priority Date Filing Date
IL105607A IL105607A (en) 1992-05-07 1993-05-05 Polycyclic macrolides containing atomic tetra, their preparation and pharmaceutical preparations containing them

Country Status (25)

Country Link
US (1) US5514685A (da)
EP (1) EP0569337B1 (da)
JP (1) JP2788392B2 (da)
KR (1) KR100292311B1 (da)
CN (1) CN1037773C (da)
AT (1) ATE155787T1 (da)
AU (1) AU668152B2 (da)
CA (1) CA2095659C (da)
CY (1) CY2126B1 (da)
CZ (1) CZ291773B6 (da)
DE (1) DE69312386T2 (da)
DK (1) DK0569337T3 (da)
ES (1) ES2105193T3 (da)
FI (2) FI102612B1 (da)
GR (1) GR3024754T3 (da)
HU (2) HUT66531A (da)
IL (1) IL105607A (da)
MY (1) MY109602A (da)
NO (1) NO305865B1 (da)
NZ (1) NZ247553A (da)
PH (1) PH30456A (da)
RU (1) RU2126009C1 (da)
SG (1) SG47011A1 (da)
SK (1) SK282061B6 (da)
TW (1) TW330936B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY110603A (en) * 1993-05-27 1998-08-29 Novartis Ag Tetrahydropyran derivatives
CN1089233C (zh) 1994-10-26 2002-08-21 诺瓦蒂斯有限公司 药物组合物
IL115742A (en) 1994-10-26 2000-06-01 Novartis Ag Pharmaceutical compositions comprising a difficultly soluble active agent a hydrophilic phase a lipophilic phase and a surfactant
BRPI9909201B8 (pt) 1998-03-26 2021-05-25 Astellas Pharma Inc formulação de composto de macrolídeo de liberação controlada
GB9826656D0 (en) 1998-12-03 1999-01-27 Novartis Ag Organic compounds
US7063857B1 (en) 1999-04-30 2006-06-20 Sucampo Ag Use of macrolide compounds for the treatment of dry eye
GB0008785D0 (en) 2000-04-10 2000-05-31 Novartis Ag Organic compounds
CA2492989C (en) 2002-07-23 2012-11-20 Novartis Ag Ophthalmic ointment composition comprising a drug, an ointment base and a solubilizing/dispersing agent
KR100469917B1 (ko) * 2002-09-09 2005-02-02 (주)조은식품 구수한 호박씨가 첨가된 호박엿 및 그 제조방법
KR100745493B1 (ko) * 2005-12-16 2007-08-03 주식회사농심 조직감이 향상된 사출 스낵 및 그 제조 방법
EP2552923B1 (en) * 2010-04-02 2014-03-26 Janssen R&D Ireland Macrocyclic integrase inhibitors
CN107106588B (zh) 2014-10-28 2020-08-11 山口晃史 用于改善妊娠状态的药剂及其使用
CN112533599A (zh) 2018-08-10 2021-03-19 山口晃史 与母体和胎儿的关系中的体液免疫相关的疾病的治疗药
AU2019401108A1 (en) 2018-12-18 2021-07-01 Koushi Yamaguchi Agent for improving infertility, recurrent miscarriage, and state of pregnancy

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
US5254562A (en) * 1984-12-03 1993-10-19 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
EP0364031B1 (en) * 1988-10-12 1992-12-23 Merck & Co. Inc. Hydroxide mediated fk-506 rearrangement process
CA1316916C (en) * 1988-10-12 1993-04-27 David Askin Hydroxide mediated fk-506 rearrangement product
CA2032159A1 (en) * 1989-06-14 1990-12-15 Andrew J. F. Edmunds Heteroatoms-containing tricyclic compounds
EP0413532A3 (en) * 1989-08-18 1991-05-15 Fisons Plc Macrocyclic compounds
IE904050A1 (en) * 1989-11-13 1991-05-22 Merck & Co Inc Aminomacrolides and derivatives having immunosuppressive¹activity
US5260301A (en) * 1990-03-01 1993-11-09 Fujisawa Pharmaceutical Co., Ltd. Pharmaceutical solution containing FK-506
GB2246350A (en) * 1990-07-23 1992-01-29 Fujisawa Pharmaceutical Co Tricyclo compounds
EP0480623A1 (en) * 1990-10-11 1992-04-15 Merck & Co. Inc. New halomacrolides and derivatives having immunosuppressive activity
WO1992013862A1 (en) * 1991-02-05 1992-08-20 Fujisawa Pharmaceutical Co., Ltd. Lactone compounds
WO1993004679A1 (en) * 1991-09-05 1993-03-18 Abbott Laboratories Macrocyclic immunomodulators

Also Published As

Publication number Publication date
AU3839393A (en) 1993-11-11
KR100292311B1 (ko) 2001-09-17
CZ291773B6 (cs) 2003-05-14
DK0569337T3 (da) 1998-01-19
CA2095659C (en) 2005-08-09
US5514685A (en) 1996-05-07
SK282061B6 (sk) 2001-10-08
JP2788392B2 (ja) 1998-08-20
RU2126009C1 (ru) 1999-02-10
ES2105193T3 (es) 1997-10-16
DE69312386T2 (de) 1998-01-29
JPH0641144A (ja) 1994-02-15
FI932035A0 (fi) 1993-05-05
GR3024754T3 (en) 1997-12-31
FI932035A (fi) 1993-11-08
PH30456A (en) 1997-05-28
CA2095659A1 (en) 1993-11-08
HU9301190D0 (en) 1993-07-28
KR940005631A (ko) 1994-03-22
CZ82993A3 (en) 1994-01-19
HU211135A9 (en) 1995-10-30
SK43593A3 (en) 1995-07-11
CN1083486A (zh) 1994-03-09
EP0569337A1 (en) 1993-11-10
DE69312386D1 (de) 1997-08-28
CY2126B1 (en) 2002-06-21
FI102612B (fi) 1999-01-15
FI102612B1 (fi) 1999-01-15
TW330936B (en) 1998-05-01
MY109602A (en) 1997-03-31
FI982476A0 (fi) 1998-11-16
IL105607A0 (en) 1993-09-22
NO931627L (no) 1993-11-08
AU668152B2 (en) 1996-04-26
NZ247553A (en) 1995-07-26
NO931627D0 (no) 1993-05-05
ATE155787T1 (de) 1997-08-15
CN1037773C (zh) 1998-03-18
NO305865B1 (no) 1999-08-09
HUT66531A (en) 1994-12-28
SG47011A1 (en) 1998-03-20
EP0569337B1 (en) 1997-07-23

Similar Documents

Publication Publication Date Title
KR0166074B1 (ko) 헤테로원자-함유 트리사이클릭 화합물
EP0109047B1 (en) Total synthesis of antitumor antibiotics
US5514685A (en) Heteroatom-containing tricyclic compounds
AU641410B2 (en) Antiinflammatory and immunosuppressant triheterocyclic FK506-like compounds and processes for their preparation
JPH05194530A (ja) 免疫抑制活性を有するフルオロマクロライド
US5493019A (en) Tetrahydropyran derivatives
US5352671A (en) Heteroatoms-containing tricyclic compounds
AU648806B2 (en) Cyclopentylvinyl substituted macrolides
US5200411A (en) Heteroatoms-containing tricyclic compounds
FR2639637A1 (fr) Derives cycliques et leurs metabolites, leur preparation et leur utilisation comme medicaments
PL173506B1 (pl) Związki tricykliczne zawierające heteroatomy
IL96268A (en) Tricyclic macrolides containing the trout atoms, converted by cycloalkyl, their preparation and pharmaceutical preparations containing them

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees